Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in ...

Speakers include Parizad A. Elchidana, ACG World; Dr. Kiran Marthak, Veeda Life Sciences; Dr. Ravikrishna Chebolu, CSIR ...

The newly approved regimen offers a chemotherapy-free perioperative approach and is authorised for use across all 27 EU ...

With the approval, Cosentyx becomes the first and only interleukin-17A (IL-17A) inhibitor approved in Europe for adults with ...

The initiative will initially focus on patients with desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas ...

Allergan Aesthetics is presenting new clinical findings at AMWC Dubai.

Launched in collaboration with Ameelio Healthcare Private Limited, the laboratory is aimed at expanding access to affordable, ...

Prolific has reported a productivity milestone of 21 grams per litre in a 15-day intensified fed-batch run for a monoclonal ...

Biotech firm Zealand Pharma has reported positive Phase 1 multiple ascending dose (MAD) results for ZP9830, its ...

Lysine is one of the most limiting amino acids in ruminant nutrition and a critical driver of animal performance ...

Eli Lilly and Company has reported positive one-year results from a Phase 3 trial of Omvoh (mirikizumab-mrkz) in children and adolescents aged 6 to 17 with moderately to severely active ulcerative ...

The initiative aims to address persistent gaps in healthcare, including late diagnosis, delays in specialist referrals ...